Life Molecular Imaging (LMI) and SOFIE Biosciences (SOFIE) have expanded their strategic partnership and licensing agreement to provide and distribute Neuraceq® out of SOFIE’s radiopharmaceutical manufacturing site located in Somerset, NJ, resulting in increased availability of Neuraceq® for imaging centers, physicians, and patients with cognitive impairment in eastern Pennsylvania, New Jersey, and New York.